Annual revenue nearly halved from KRW 317.0bn in 2022 to KRW 164.5bn in 2023, then drifted lower to KRW 167.8bn in 2024 and KRW 155.5bn in 2025. The operating margin held at a solid 16.9-18.3% range from 2022 to 2024 but collapsed to 2.7% in 2025, indicating significant deterioration in core profitability.
Owner net profit was stable at KRW 25.7bn in 2022, KRW 16.4bn in 2023, and KRW 15.2bn in 2024, but jumped to KRW 131.4bn in 2025 — a figure far larger than that year's operating profit of just KRW 4.2bn, suggesting most of it stemmed from a non-operating, likely one-time item.
On a quarterly basis, after a weak Q2 2025 (revenue KRW 7.0bn, operating loss KRW 17.1bn, net loss KRW 10.0bn), Q3 2025 swung to an operating profit of KRW 10.4bn on revenue of KRW 61.6bn, yet net profit reached KRW 200.3bn, far exceeding operating performance.
That quarter coincides with the scheduled change-of-control date for the Viol stake sale (September 17, 2025), suggesting a disposal gain or similar one-off item may have been recorded.
The company then swung back to losses in Q4 2025 (revenue KRW 41.1bn, operating loss KRW 1.5bn, net loss KRW 65.5bn), followed by Q1 2026 (revenue KRW 13.8bn, operating loss KRW 8.6bn, net profit KRW 3.1bn) and Q2 2026 (revenue KRW 28.8bn, operating loss KRW 5.6bn, net loss KRW 2.4bn) — three of the last five quarters posted operating losses.
Operating cash flow in 2025 was KRW 36.0bn, well below the KRW 131.4bn in owner net profit, supporting the view that a large share of net income was non-cash and one-off in nature.
The debt ratio rose from 29.1% in 2022 to 45.2% in 2024 before easing back to 32.5% in 2025, keeping the balance sheet within a broadly stable range.